Auro Laboratories Stock Screener | Share Price & Fundamental Analysis
AUROLAB
Pharmaceuticals
Screen Auro Laboratories share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹236.65
▼
-6.50 (-2.67%)
Market Cap
₹165.20 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
3.88
EPS (TTM)
₹2.95
Dividend Yield
-
Debt to Equity
0.81
52W High
₹296.15
52W Low
₹179.25
Operating Margin
1.00%
Profit Margin
-
Revenue (TTM)
₹3.00
EBITDA
-
Net Income
-
Total Assets
₹99.00
Total Equity
₹43.00
Auro Laboratories Share Price History - Stock Screener Chart
Screen AUROLAB historical share price movements with interactive charts. Analyze price trends and patterns.
Auro Laboratories Company Profile - Fundamental Screener
Screen Auro Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AUROLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE292C01011
Auro Laboratories Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen AUROLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 99 | 86 | 56 | 55 | 42 | 32 | 34 | 30 | 27 | 26 |
| Current Assets | 22 | 31 | 36 | 38 | 28 | 18 | 19 | 16 | 14 | 12 |
| Fixed Assets | 21 | 22 | 13 | 14 | 14 | 14 | 15 | 13 | 13 | 9 |
| Liabilities | ||||||||||
| Total Liabilities | 99 | 86 | 56 | 55 | 42 | 32 | 34 | 30 | 27 | 26 |
| Current Liabilities | 35 | 20 | 4 | 3 | 4 | 5 | 10 | 11 | 11 | 7 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 43 | 42 | 34 | 32 | 29 | 22 | 17 | 13 | 9 | 9 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves & Surplus | 37 | 36 | 28 | 25 | 22 | 15 | 11 | 7 | 3 | 2 |
Screen AUROLAB income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Jun | 2025-Sept | 2024-Jun | 2024-Sept |
|---|---|---|---|---|
| Revenue | 3 | 10 | 6 | 3 |
| Expenses | 3 | 7 | 4 | 2 |
| EBITDA | 0 | 3 | 2 | 1 |
| Operating Profit % | 1.00% | 27.00% | 23.00% | 23.00% |
| Depreciation | 0 | 1 | 0 | 0 |
| Interest | 0 | 1 | 0 | 0 |
| Profit Before Tax | 0 | 2 | 1 | 1 |
| Tax | 0 | 1 | 0 | 0 |
| Net Profit | 0 | 1 | 1 | 0 |
| EPS | -0.17 | 1.15 | 1.21 | 0.57 |
Auro Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen AUROLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 6 | 19 | 3 | -7 | 13 | 9 | 7 | 6 | 7 | 8 |
| Investing Activities | -25 | -39 | -5 | -5 | -4 | -2 | -3 | -3 | -2 | -2 |
| Financing Activities | 18 | 19 | -8 | 10 | -1 | -6 | -2 | -2 | -4 | -5 |
| Net Cash Flow | -1 | -1 | -10 | -2 | 9 | 2 | 2 | 1 | 1 | 0 |
Screen AUROLAB shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.18% | 52.18% | 52.18% | 52.15% | 52.15% | 52.15% | 52.15% | 52.09% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 36.57% | 36.42% | 36.35% | 35.03% | 35.33% | 35.42% | 36.15% | 39.87% |
| Other Holding | 11.25% | 11.40% | 11.47% | 12.81% | 12.52% | 12.43% | 11.69% | 8.03% |
| Shareholder Count | 9,102 | 8,916 | 8,860 | 9,441 | 9,335 | 9,266 | 9,265 | 10,906 |
Auro Laboratories Dividend Screener - Share Yield Analysis
Screen AUROLAB dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Auro Laboratories Index Membership - Market Screener Classification
Screen AUROLAB by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Auro Laboratories Market Events Screener - Corporate Actions
Screen AUROLAB market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -2.73% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.46% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -3.89% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 0.06% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -2.41% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | -0.22% |
| 2024-06-28 | 2024-06-28 | Annual General Meeting | NA | -13.67% |
Auro Laboratories Competitors Screener - Peer Comparison
Screen AUROLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 424,106 | 40.53 | 54,729 | 9.71% | 10,980 | 49.55 |
| Divis Laboratories | 172,143 | 69.57 | 9,712 | 18.67% | 2,191 | 56.33 |
| Torrent Pharmaceuticals | 129,388 | 60.33 | 11,539 | 6.99% | 1,911 | 61.47 |
| Cipla | 122,044 | 22.48 | 28,410 | 7.12% | 5,291 | 49.47 |
| Dr Reddys Laboratories | 107,048 | 18.68 | 33,741 | 16.73% | 5,725 | 60.05 |
| Lupin | 96,672 | 22.34 | 22,910 | 13.74% | 3,306 | 65.28 |
| Zydus Life Science | 93,087 | 18.37 | 23,511 | 18.55% | 4,615 | 40.07 |
| Mankind Pharma | 92,025 | 50.91 | 12,744 | 20.90% | 2,007 | 45.53 |
| Aurobindo Pharma | 71,526 | 20.79 | 32,346 | 9.43% | 3,484 | 59.88 |
| Alkem Laboratories | 67,148 | 27.88 | 13,458 | 3.70% | 2,216 | 49.80 |
Auro Laboratories Company Announcements - News Screener
Screen AUROLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Grant Of Certificate Of Good Manufacturing Practices From World Health Organisation (WHQ"). | View |
| 2025-11-12 | Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of The Board Meeting Dated November 12 2025 | View |
| 2025-11-06 | Board Meeting Intimation for Unaudited Financial Results Of The Company For Quarter And Half Year Ended September 30 2025. | View |
| 2025-10-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-03 | Regulation 36(1)(B) Of SEBI (LODR) Regulations | View |
| 2025-09-03 | Reg. 34 (1) Annual Report. | View |
| 2025-09-03 | Notice Of 36Th Annual General Meeting (AGM) Scheduled On Thursday September 25 2025 | View |
| 2025-09-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-23 | Appointment of Company Secretary and Compliance Officer | View |
| 2025-08-23 | Board Meeting Outcome for Outcome Of Board Meeting Dated August 23 2025 | View |
| 2025-08-23 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | View |
| 2025-08-23 | Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors | View |
| 2025-08-20 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-14 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | View |